PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Third Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Sotiria Hospital, Athens, Greece.\', \'Faculty of Medicine, School of Health Science, University of Thessaly, Larissa, Greece.\', \'School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.\', \'Department of Cardiology, General Hospital of Athens \'G. Gennimatas\', Athens, Greece.\', \'Department of Cardiovascular Medicine, University of Oxford, Oxford, UK.\', \'Oxford Heart Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, UK.\', \'Departmentof Cardiology and Angiology, Faculty of Medicine of the Eberhard Karls University Tübingen, Tübingen, Germany.\', \'Department of Clinical Biochemistry, Royal Free Hospital Campus, University College London Medical School, University College London (UCL), UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.2174/1570161119666210824160332
?:doi
?:hasPublicationType
?:journal
  • Current vascular pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34431465
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.715
?:rankingScore_hIndex
  • 51
is ?:relation_isRelatedTo_publication of
?:title
  • Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all